Download Files:
Products Details
Product Description
– Pagibaximab is a chimeric IgG1 antibody recognizing the surface component lipoteichoic acid of S. aureus and S. epidermidis. Pagibaximab can be used to prevent staphylococcal sepsis[1].
Web ID
– HY-P99309
Shipping
– Room temperature
Applications
– COVID-19-immunoregulation
Molecular Formula
– N/A
References
– [1]Weisman LE, et, al. A randomized study of a monoclonal antibody (pagibaximab) to prevent staphylococcal sepsis. Pediatrics. 2011 Aug;128(2):271-9.
CAS Number
– 595566-61-3
Molecular Weight
– 146.07 (kDa)
SMILES
– [Pagibaximab]
Clinical Information
– Phase 3
Research Area
– Infection
Solubility
– H2O
Target
– Bacterial
Pathway
– Anti-infection
Product type
– Inhibitory Antibodies
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
